Fineotex Chem

Fineotex Chemical Limited reported a flattish total income of Rs. 558 crores for FY25. Gross profit stood at Rs. 205 crores, maintaining stable margins at 38.57%. However, EBITDA softened by 222 basis points to 23.85% (Rs. 127 crores) due to strategic investments in CAPEX and brand-building initiatives. PAT for the year was Rs. 109 crores, a decrease from Rs. 121 crores in the previous year, resulting in a PAT margin of 20.48%. The company generated Rs. 69.33 crores in operating cash flows, with a healthy CFO to EBITDA ratio of 54.50%.

The company is actively diversifying its business portfolio, with water treatment and oil & gas segments delivering strong performance and substantial increases in both volumes and value contributions. A key innovation is AquaStrike Premium, a biotechnology-based mosquito control solution formulated with Azadirachtin, which has received Central Insecticide Board approval and demonstrated a 100% mortality rate in 2-3 hours. This product is poised to open new opportunities in the public health domain. Fineotex also added 25 new customers and developed 30 new products during Q4 FY25, reinforcing its focus on innovation.

Fineotex's greenfield expansion initiative is progressing well and is targeted to commence operations by Q2 FY26. This new facility will add 15,000 metric tonnes per annum of capacity, increasing the total installed capacity to 1,20,000 metric tonnes. The company has invested approximately Rs. 110-115 crores in CAPEX over the last 15 months, including the new plant and corporate office. With a current cash balance of Rs. 352 crores and strong internal accruals, management is confident in funding future expansions without external debt concerns. Capacity utilization for FY25 was approximately 59-60%.

The FMCG, cleaning, and hygiene segment experienced a temporary softness in volumes during Q4 FY25, with the detergent/FMCG sub-segment seeing an 18% volume drop. This was attributed to rising raw material prices and a consumer shift towards cheaper products and liquid detergents. Management views this as a transitional quarter, with underlying demand fundamentals remaining intact. They anticipate a pickup in volumes in the coming quarters, driven by geographical expansion, new product launches, and increasing demand for sustainable solutions.

The textile chemical segment remained stable, with volumes growing 15% and revenue 10% in FY25, and a strong revival is expected from June onwards. Fineotex is actively pursuing opportunities in the Middle East and US markets for oil & gas, noting that global companies are diverting supply chains to India. The company's capacities are fungible, allowing it to produce various chemicals for these industries with minimal additional capex (estimated Rs. 20-30 crores for specific product lines). The India-UK Free Trade Agreement is also expected to benefit Fineotex by improving market access and reducing tariffs.

The company undertook a fundraise of Rs. 342 crores in FY25, with the promoter contributing Rs. 44 crores. Further warrant conversions by the promoter (Rs. 33 crores remaining) are expected by November. Management emphasized that the company's strong cash position of Rs. 352 crores and robust internal accruals provide ample liquidity for both organic and inorganic growth opportunities. They stated that even if the remaining warrant conversions do not fully materialize, it would not affect the company's operations or growth plans, as the retained 25% would be tax-free and added to reserves.